This is a community-generated profile. If you would like to claim it, please .
Mersana Therapeutics Funding
$0
77 rounds
Mersana Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 7 rounds and is valued at $0. Their most recent funding was raised on June 16, 2016.
Funding Rounds
B
$35000000A
$14500000Series AApr 2014
A
$27000000Series AJul 2012
U
$10000000U
$2500000U
$21000000UnknownNov 2005
Investors of Mersana Therapeutics
PureTech Health
Rho Capital Partners
Arrowpoint Partners
Rounds
C
Takeda Pharmaceutical
Rounds
C
Rock Springs Capital
Rounds
C
Wellington Management
Investment management across global public and private markets
Rounds
C
ProQuest Investments
Rounds
A
U
Harris & Harris Group
Rounds
U
Rounds
C
B
A
A